Clinical Trial Update: A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing safety of lebrikizumab to topical corticosteroids in adults with atopic dermatitis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Lebrikizumab (lebrikizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED